<DOC>
	<DOC>NCT02580396</DOC>
	<brief_summary>This feasibility study will be conducted in order to provide proof of concept for the CanADVICE+® system comprising a smart phone app and a healthcare organization server side application based on Web 2 technologies. The main objective of this project is to optimise pharmaceutical counselling services by providing drug related information, in a digital format, to patients with metastatic breast cancer receiving Capecitabine.</brief_summary>
	<brief_title>Evaluation Of CanADVICE+®M-Health System To Support Breast Cancer Patients Receiving Capecitabine</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>Patients diagnosed with metastatic breast cancer Commencing first cycle of Capecitabine Familiar with and own an android smartphone Willing to participate Patients &lt;18 years Patients taking part in any other trial containing Capecitabine Chemotherapynaïve patients</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>